Page last updated: 2024-09-04

tx 3301 and Apoplexy

tx 3301 has been researched along with Apoplexy in 36 studies

Research

Studies (36)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	29 (80.56)	29.6817
2010's	6 (16.67)	24.3611
2020's	1 (2.78)	2.80

Authors

Authors	Studies
DeSantis, DJ; Gerova, L; Grady, DW; Patel, PB	1
Bath, PM; Cotton, D; Diener, HC; Sacco, RL; Sha, N; Weber, R; Weimar, C	1
Hoover, PL; Mold, JW	1
Brahin, E; Dessain, S; Ezekowitz, MD; Gracely, E; Nagarakanti, R; Notaro, LA; Usman, MH	1
Atar, OD; Booze, C; Eisert, C; Hanley, D; Sabaeva, E; Serebruany, V	1
Meyer, D	1
Crown, N; Mysak, T	1
Eisert, C; Fong, A; Hanley, D; Sani, Y; Schevchuck, A; Serebruany, V	1
Horie, Y; Ikeda, Y; Uchiyama, S; Urano, Y; Yamaguchi, T	1
Bath, P; Hogg, C; Pocock, S; Tracy, M	1
Collins, R; Coughlan, T; Cox, D; Kinsella, JA; McCabe, DJ; Murphy, RP; O'Neill, D; Tobin, WO	1
Malinin, AI; Sane, DC; Serebruany, VL	1
Lenz, T; Wilson, A	1
Haberl, R	1
Redman, AR; Ryan, GJ	1
Fisher, M; Moonis, M	1
Atar, D; Ferguson, JJ; Hanley, DF; Serebruany, VL	1
Marissal, JP; Selke, B	1
Lindberg, M	1
Atar, D; Hennekens, CH; Jilma, B; Malinin, AI; Sane, DC; Serebruany, VL; Takserman, A	1
Gray, CS; Morton, JA; Newton, J	1
Horton, HL	1
Ackerstaff, RG; de Borst, GJ; de Vries, JP; Hilgevoord, AA; Moll, FL; van de Pavoordt, HD; van der Mee, M	1
Macdonald, S	1
Sedrakyan, A; Shih, C	1
Cohen, SN	1
Hilleman, DE; Lenz, TL	1
Bergmann, SR	1
Scheen, AJ	1
Kipp, A	1
Hansen, DB	1

Reviews

8 review(s) available for tx 3301 and Apoplexy

Article	Year
Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble? The American journal of cardiology, 2009, Apr-15, Volume: 103, Issue:8 Topics: Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome	2009
Antiplatelets and stroke outcomes: state of the science. Critical care nursing clinics of North America, 2009, Volume: 21, Issue:4 Topics: Arachidonic Acid; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Combinations; Evidence-Based Practice; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Risk Reduction Behavior; Safety; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome	2009
Safety of fixed-dose aspirin-extended-release dipyridamole in patients with ischemic heart disease. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, May-01, Volume: 67, Issue:9 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Humans; Meta-Analysis as Topic; Myocardial Ischemia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke	2010
Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke. Clinical pharmacokinetics, 2003, Volume: 42, Issue:10 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine	2003
Aggrenox((R)) versus other pharmacotherapy in preventing recurrent stroke. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:1 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Cost-Benefit Analysis; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Secondary Prevention; Stroke; Ticlopidine	2004
Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use. Expert review of cardiovascular therapy, 2003, Volume: 1, Issue:4 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine	2003
Aggrenox: a fixed-dose combination of aspirin and dipyridamole. The Annals of pharmacotherapy, 2000, Volume: 34, Issue:11 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Stroke	2000
[Pharma-clinics. The drug of the month. Dipyridamole-acetylsalicylic acid combination (Aggrenox)]. Revue medicale de Liege, 2000, Volume: 55, Issue:10 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Primary Prevention; Stroke; Treatment Outcome	2000

Trials

7 trial(s) available for tx 3301 and Apoplexy

Article	Year
Discontinuation of antiplatelet study medication and risk of recurrent stroke and cardiovascular events: results from the PRoFESS study. Cerebrovascular diseases (Basel, Switzerland), 2013, Volume: 35, Issue:6 Topics: Aged; Aged, 80 and over; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dipyridamole; Drug Combinations; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome	2013
Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation. Thrombosis and haemostasis, 2009, Volume: 102, Issue:3 Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Erythrocytes; Female; Humans; Ischemia; Leukocytes; Male; Middle Aged; Risk Factors; Spectrometry, Fluorescence; Stroke; Time Factors; Treatment Outcome	2009
Effects of Aggrenox and aspirin on plasma endothelial nitric oxide synthase and oxidised low-density lipoproteins in patients after ischaemic stroke. The AGgrenox versus aspirin therapy evaluation (AGATE) biomarker substudy. Thrombosis and haemostasis, 2011, Volume: 105, Issue:1 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Atherosclerosis; Biomarkers; Case-Control Studies; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Lipoproteins, LDL; Male; Middle Aged; Nitric Oxide Synthase Type III; Pharmacokinetics; Platelet Aggregation Inhibitors; Stroke	2011
The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial. Cerebrovascular diseases (Basel, Switzerland), 2011, Volume: 31, Issue:6 Topics: Aged; Asian People; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Treatment Outcome	2011
Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage? American journal of hematology, 2003, Volume: 72, Issue:4 Topics: Adenosine Diphosphate; Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Capsules; Dipyridamole; Dose-Response Relationship, Drug; Drug Combinations; Epinephrine; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; Stroke; Time Factors	2003
Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial. European journal of pharmacology, 2004, Sep-24, Volume: 499, Issue:3 Topics: Aged; Antigens, CD; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; CD40 Ligand; Dipyridamole; Drug Combinations; Female; Flow Cytometry; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Function Tests; Platelet Membrane Glycoprotein IIb; Platelet Membrane Glycoproteins; Stroke; Tetraspanin 24; Time Factors; Treatment Outcome	2004
Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoring. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2007, Volume: 34, Issue:2 Topics: Aged; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dextrans; Dipyridamole; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Hemorrhage; Humans; Intracranial Embolism; Ischemic Attack, Transient; Male; Middle Aged; Middle Cerebral Artery; Pilot Projects; Platelet Aggregation Inhibitors; Postoperative Care; Prospective Studies; Stroke; Ticlopidine; Treatment Outcome; Ultrasonography, Doppler, Transcranial	2007

Other Studies

21 other study(ies) available for tx 3301 and Apoplexy

Article	Year
The Anti-Platelet Anomaly: Aspirin/Dipyridamole-Induced Acute Pancreatitis. The American journal of medicine, 2020, Volume: 133, Issue:6 Topics: Aged, 80 and over; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Cytochrome P-450 CYP2C19; Dual Anti-Platelet Therapy; Female; Humans; Pancreatitis; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Treatment Failure	2020
Does Aggrenox (aspirin/dipyridamole) reduce the risk of recurrent stroke to a greater degree than aspirin alone? The Journal of the Oklahoma State Medical Association, 2008, Volume: 101, Issue:5 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Recurrence; Stroke	2008
Calculation of numbers-needed-to-treat in parallel group trials assessing ordinal outcomes: case examples from acute stroke and stroke prevention. International journal of stroke : official journal of the International Stroke Society, 2011, Volume: 6, Issue:6 Topics: Aged; Algorithms; Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Confidence Intervals; Dipyridamole; Drug Combinations; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Research Design; Sample Size; Stroke; Tissue Plasminogen Activator; Treatment Outcome	2011
Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®). Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2013, Volume: 22, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Brain Ischemia; Clopidogrel; Cross-Sectional Studies; Dipyridamole; Drug Combinations; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stroke; Ticlopidine	2013
[Recurrence prophylaxis for stroke patients. Which platelet inhibitor combination protects best?]. MMW Fortschritte der Medizin, 2003, Jul-24, Volume: 145, Issue:29-30 Topics: Angiotensin II Type 1 Receptor Blockers; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Telmisartan; Ticlopidine	2003
[PRoFESS study presented. Change in secondary prevention]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Controlled Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Placebos; Platelet Aggregation Inhibitors; Recurrence; Risk; Stroke; Telmisartan; Ticlopidine; Time Factors	2003
[ASS and dipyridamole combination. A decisive contribution to secondary prevention after stroke]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Recurrence; Stroke	2003
[Secondary prevention after stroke. Doubled performs better]. MMW Fortschritte der Medizin, 2003, Nov-13, Volume: 145, Issue:46 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Controlled Clinical Trials as Topic; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Placebos; Platelet Aggregation Inhibitors; Stroke	2003
[After stroke or TIA. Double protection by second platelet inhibitor]. MMW Fortschritte der Medizin, 2003, Dec-11, Volume: 145, Issue:50 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Placebos; Practice Guidelines as Topic; Risk; Stroke	2003
Noncompliance in antiplatelet trials: the AGATE trial perspective. Stroke, 2004, Volume: 35, Issue:6 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Controlled Clinical Trials as Topic; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Stroke; Treatment Refusal	2004
Economic assessment of the secondary prevention of ischaemic stroke with dipyridamole plus aspirin (Aggrenox/Asasantin) in France. PharmacoEconomics, 2004, Volume: 22, Issue:10 Topics: Adolescent; Adult; Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Confidence Intervals; Cost-Benefit Analysis; Dipyridamole; Double-Blind Method; Drug Combinations; Female; France; Humans; Male; Middle Aged; Monte Carlo Method; Randomized Controlled Trials as Topic; Retrospective Studies; Stroke	2004
[Asasantin Retard or Persantin Retard+ASA?]. Ugeskrift for laeger, 2004, Jun-07, Volume: 166, Issue:24 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Stroke	2004
Counting the true cost of antiplatelet therapy for stroke prevention. Age and ageing, 2005, Volume: 34, Issue:3 Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Drug Combinations; Female; Gastrointestinal Diseases; Humans; Male; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine; United Kingdom	2005
Secondary stroke prevention and antiplatelet therapy. Journal of the American College of Cardiology, 2006, Jun-20, Volume: 47, Issue:12 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Stroke	2006
Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoring. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2007, Volume: 34, Issue:2 Topics: Aged; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dextrans; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Hemorrhage; Humans; Intracranial Embolism; Ischemic Attack, Transient; Male; Middle Aged; Middle Cerebral Artery; Pilot Projects; Platelet Aggregation Inhibitors; Postoperative Care; Randomized Controlled Trials as Topic; Research Design; Stroke; Ticlopidine; Treatment Outcome; Ultrasonography, Doppler, Transcranial	2007
Improving depiction of benefits and harms: analyses of studies of well-known therapeutics and review of high-impact medical journals. Medical care, 2007, Volume: 45, Issue:10 Supl 2 Topics: Antipsychotic Agents; Appetite Depressants; Aspirin; Aspirin, Dipyridamole Drug Combination; Contraceptives, Oral; Decision Making; Dipyridamole; Drug Combinations; Drug Evaluation; Evidence-Based Medicine; Fibrinolytic Agents; Hormone Replacement Therapy; Humans; Information Dissemination; Pharmacoepidemiology; Phenylpropanolamine; Review Literature as Topic; Risk Assessment; Stroke; Tissue Plasminogen Activator	2007
Aggrenox: a combination of antiplatelet drugs for stroke prevention. The Medical letter on drugs and therapeutics, 2000, Feb-07, Volume: 42, Issue:1071 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Dipyridamole; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Fees, Pharmaceutical; Humans; Platelet Aggregation Inhibitors; Stroke	2000
Dipyridamole plus aspirin in cerebrovascular disease. Archives of neurology, 2000, Volume: 57, Issue:7 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Research Design; Risk Assessment; Scientific Misconduct; Stroke; Treatment Outcome	2000
Aggrenox and stress testing. Circulation, 2001, Feb-27, Volume: 103, Issue:8 Topics: Adenosine; Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; Ischemia; Platelet Aggregation Inhibitors; Stroke; Vasodilator Agents	2001
Second stroke. Journal of dental hygiene : JDH, 2000,Spring, Volume: 74, Issue:2 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Chemoprevention; Dipyridamole; Drug Approval; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Recurrence; Stroke; United States; United States Food and Drug Administration	2000
Antithrombotic drugs for secondary stroke prophylaxis--a comment. Pharmacotherapy, 2001, Volume: 21, Issue:8 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dipyridamole; Drug Combinations; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine	2001